Medical Research
(H54)
IRS Verified
DX Registered
990 on File
PEDIATRIC EPILEPSY RESEARCH FOUNDATION
Financial strength (30%)
70/100
Reliability (20%)
55/100
Effectiveness (25%)
41/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$2.7M
Total Revenue
$1.4M
Total Expenses
$32.9M
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
67.6%
Fundraising Efficiency
N/A
Operating Reserve
287.58x
Liability-to-Asset
6.3%
Revenue Diversification
99.7%
Executive Compensation
$87K
Compared with Peers
FY 2024
Compared with 332 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
67.6% | 83.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
287.6 mo | 12.8 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
6.3% | 10.1% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.7% | 90.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-11.8% | 12.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
12.9% | 11.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
49.5% | 2.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $2.7M | $1.4M | $32.9M | 67.6% | — |
| 2023 | $3.1M | $1.2M | $32.2M | 62.5% | — |
| 2022 | $4.7M | $2.4M | $27.0M | 86.1% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.